Your browser doesn't support javascript.
loading
Retuning of Mouse NK Cells after Interference with MHC Class I Sensing Adjusts Self-Tolerance but Preserves Anticancer Response.
Wagner, Arnika Kathleen; Wickström, Stina Linnea; Tallerico, Rossana; Salam, Sadia; Lakshmikanth, Tadepally; Brauner, Hanna; Höglund, Petter; Carbone, Ennio; Johansson, Maria Helena; Kärre, Klas.
  • Wagner AK; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Wickström SL; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Tallerico R; Department of Experimental and Clinical Medicine, University of "Magna Graecia," Catanzaro, Italy.
  • Salam S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Lakshmikanth T; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Brauner H; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Höglund P; Center for Hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Carbone E; Department of Experimental and Clinical Medicine, University of "Magna Graecia," Catanzaro, Italy.
  • Johansson MH; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Kärre K; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. klas.karre@ki.se.
Cancer Immunol Res ; 4(2): 113-23, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26589766
ABSTRACT
Natural killer (NK) cells are most efficient if their targets do not express self MHC class I, because NK cells carry inhibitory receptors that interfere with activating their cytotoxic pathway. Clinicians have taken advantage of this by adoptively transferring haploidentical NK cells into patients to mediate an effective graft-versus-leukemia response. With a similar rationale, antibody blockade of MHC class I-specific inhibitory NK cell receptors is currently being tested in clinical trials. Both approaches are challenged by the emerging concept that NK cells may constantly adapt or "tune" their responsiveness according to the amount of self MHC class I that they sense on surrounding cells. Hence, these therapeutic attempts would initially result in increased killing of tumor cells, but a parallel adaptation process might ultimately lead to impaired antitumor efficacy. We have investigated this question in two mouse models inhibitory receptor blockade in vivo and adoptive transfer to MHC class I-disparate hosts. We show that changed self-perception via inhibitory receptors in mature NK cells reprograms the reactivity such that tolerance to healthy cells is always preserved. However, reactivity against cancer cells lacking critical MHC class I molecules (missing self-reactivity) still remains or may even be increased. This dissociation between activity against healthy cells and tumor cells may provide an answer as to why NK cells mediate graft-versus-leukemia effects without causing graft-versus-host disease and may also be utilized to improve immunotherapy.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Antígenos de Histocompatibilidad Clase I / Tolerancia Inmunológica / Neoplasias Límite: Animals Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Antígenos de Histocompatibilidad Clase I / Tolerancia Inmunológica / Neoplasias Límite: Animals Idioma: En Año: 2016 Tipo del documento: Article